List of articles in "Drug" category - Page 342

Cefditoren is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef by Vansen Pharma Inc.Cefditoren is also marketed under the name Meiact.

Ceftibuten is a third-generation cephalosporin antibiotic. It is an orally-administered agent with 2 dosage forms capsule or oral suspension. It is marketed by Pernix Therapeutics under the trade name Cedax.It […]

Nepafenac is a non-steroidal anti-inflammatory drug (NSAID) usually sold as a prescription eye drop 0.1% solution. Nepafenac is manufactured by Alcon and sold under the trade name Nevanac.

Exforge is the brand name of an oral blood pressure lowering medication medication which combines two medications in a film-coated tablet. It contains amlodipine a dihydropyridine-type calcium channel blocker and […]

Telapristone (proposed trade names Proellex and Progenta) is an investigational selective progesterone receptor modulator tested for treatment of progesterone sensitive myomata. CDB-4124 was originally developed the National Institutes of Health […]

Asoprisnil (J867) is an investigational selective progesterone receptor modulator developed by Schering and TAP Pharmaceutical Products tested for treatment of progesterone sensitive myomata.In 2005 Phase III trials were discontinued due […]

Ixabepilone (INN; also known as azaepothilone B codenamed BMS-247550) is an epothilone B analog developed by Bristol-Myers Squibb as a chemotherapeutic medication for cancer.It is produced by Sorangium cellulosum.

Tolmetin /ˈtɒlmətɨn/ is a non-steroidal anti-inflammatory drug of the arylalkanoic acids. It is used primarily to reduce hormones that cause pain swelling tenderness and stiffness in conditions such as osteoarthritis […]

Oxazolam is a drug which is a benzodiazepine derivative. It possesses anxiolytic anticonvulsant sedative and skeletal muscle relaxant properties. It is a prodrug for desmethyldiazepam.

Bifeprunox (DU-127090) is a novel atypical antipsychotic agent which along with SLV313 aripiprazole and SSR-181507 combines minimal D2 receptor agonism with 5-HT receptor agonism.Bifeprunox has a novel mechanism of action. […]